tsh biopharmoration Ltd (8432) — Cash Flow Reinvestment Rate
tsh biopharmoration Ltd (8432) has a Cash Flow Reinvestment Rate of 0.08x as of June 2025, reinvesting NT$3.27 Million (capex NT$3.27 Million ) from operating cash flow of NT$42.55 Million. Check 8432 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
tsh biopharmoration Ltd Cash Flow Reinvestment Rate (2017–2024)
Historical reinvestment intensity for tsh biopharmoration Ltd across 8 annual periods. Explore tsh biopharmoration Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for tsh biopharmoration Ltd (2017–2024)
Year-by-year capital reinvestment analysis for tsh biopharmoration Ltd. For live market cap and broader valuation context, see 8432 market cap overview.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.71x | NT$130.68 Million | NT$183.77 Million | NT$2.74 Million | ▼ -85.5% |
| 2023 | 4.92x | NT$166.57 Million | NT$33.87 Million | NT$5.56 Million | ▲ +297.7% |
| 2022 | 1.24x | NT$42.48 Million | NT$34.35 Million | NT$18.73 Million | ▲ +479.4% |
| 2021 | 0.21x | NT$14.66 Million | NT$68.71 Million | NT$382.00K | ▼ -98.9% |
| 2020 | 19.96x | NT$231.81 Million | NT$11.61 Million | NT$2.38 Million | ▲ +7837.8% |
| 2019 | 0.25x | NT$22.30 Million | NT$88.65 Million | NT$3.00 Million | ▼ -90.3% |
| 2018 | 2.59x | NT$162.16 Million | NT$62.62 Million | NT$5.88 Million | ▲ +74.7% |
| 2017 | 1.48x | NT$120.29 Million | NT$81.13 Million | NT$4.57 Million | — |